Cited by 21Reproductive tract infections researchHIV/AIDS Research and InterventionsCervical Cancer and HPV Research

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Gonorrhea and chlamydia case detection increased when testing increased in a multisite US HIV cohort, 2004–2014.

Open access

Abstract

OBJECTIVES: Annual screening for gonorrhea [Neisseria gonorrhoeae (NG)] and chlamydia [Chlamydia trachomatis (CT)] is recommended for all sexually active persons living with HIV but is poorly implemented. Studies demonstrating no increases in NG and/or CT (NG/CT) case detection in clinics that successfully expanded NG/CT screening raise questions about this broad screening approach. We evaluated NG/CT case detection in the HIV Research Network during 2004-2014, a period of expanding testing. METHODS: We analyzed linear time trends in annual testing (patients tested divided by all patients in care), test positivity (patients positive divided by all tested), and case detection (the number of patients with a positive result divided by all patients in care) using multivariate repeated measures logistic regression. We determined trends overall and stratified by men who have sex with men (MSM), men who have sex exclusively with women, and women. RESULTS: Among 15,614 patients (50% MSM, 26% men who have sex exclusively with women, and 24% women), annual NG/CT testing increased from 22% in 2004 to 60% in 2014 [adjusted odds ratio (AOR) per year 1.22 (1.21-1.22)]. Despite the increase in testing, test positivity also increased [AOR per year 1.10 (1.07-1.12)], and overall case detection increased from 0.8% in 2004 to 3.9% in 2014 [AOR per year 1.20 (1.17-1.22)]. Case detection was highest among MSM but increased over time among all 3 groups. CONCLUSIONS: NG/CT case detection increased as testing expanded in the population. This supports a broad approach to NG/CT screening among persons living with HIV to decrease transmission and complications of NG/CT and of HIV.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qai.0000000000001514

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 31 references

Cited by

Sorted by citations

See all 21

Metadata

Authors
Raifman, J. R., Gebo, K. A., Mathews, W. C., Korthuis, P. T., Ghanem, K. G., Aberg, J. A., Moore, R. D., Nijhawan, A. E., Monroe, A. K., Berry, S. A., & for the HIV Research Network
Affiliations
  • Johns Hopkins University (US)
  • University of California San Diego (US)
  • Oregon Health & Science University (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Raifman, Julia R.
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2017-12-01
Volume
76
Issue
4
Pages
409-416
ISSN
1525-4135 (ISSN-L)
OpenAlex
W2744332139
Cited by
21
References
31
Citations by year
2025: 1 · 2024: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 6 · 2018: 4 · 2017: 1
FWCI
3.09
Type
journal article
Language
en
Open access
Locations
  • JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institute of Mental Health (K23MH105284)
  • National Institute on Drug Abuse (U01DA036935)
  • National Institute of Allergy and Infectious Diseases (K23AI084854, K23AI112477, P30AI036214, P30AI094189, U01AI069918, T32AI102623)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords
gonorrhea, chlamydia, Neisseria gonorrhoeae, Chlamydia trachomatis, HIV, annual screening, case finding, test positivity, men who have sex with men, sexually transmitted infections
MeSH terms
Adult, Chlamydia Infections, Female, Gonorrhea, Health Promotion, Humans, Male, Mass Screening, Middle Aged, Risk-Taking, Sexual Behavior, United States, HIV Infections, Prevalence, CD4 Lymphocyte Count, Viral Load, Nucleic Acid Amplification Techniques, Coinfection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review